Rollnik, Jens D · Fortschritte der Neurologie-Psychiatrie · 2017 · DOI
Quick Summary
This review examines whether ME/CFS is a distinct disease or if its symptoms overlap significantly with depression and other conditions. The authors found that while ME/CFS affects less than 1% of the population, there is no clear biological explanation for what causes it, and there are no universally agreed-upon diagnostic criteria. They recommend trying exercise, antidepressants, and talk therapy, but caution against using aggressive immune therapies without stronger evidence.
Why It Matters
This critical review highlights ongoing diagnostic and conceptual challenges in ME/CFS that directly affect how patients are recognized and treated. Understanding debates about disease classification helps patients navigate variable clinical responses and explains why diagnostic criteria and treatment approaches differ across specialists and countries.
Observed Findings
ME/CFS prevalence is below 1% in general populations.
No consistent diagnostic criteria exist across clinical and research settings.
Significant overlap occurs between ME/CFS symptom presentation and major depression and somatoform disorders.
No convincing etiological or pathogenic models explain ME/CFS as an independent disease.
Evidence exists for symptom management with exercise, antidepressants, and psychotherapy, but not for aggressive immunotherapies.
Inferred Conclusions
The evidence base does not support ME/CFS as a biologically distinct, independent disease entity separate from psychiatric and psychosomatic conditions.
Clinicians should prioritize differential diagnosis to exclude somatic causes before attributing chronic fatigue to ME/CFS.
Immunosuppressive treatments should not be used without stronger evidence of primary neuroinflammatory pathology.
Multimodal treatment including behavioral and pharmacological interventions remains appropriate pending clearer etiological evidence.
Remaining Questions
What specific biomarkers or objective tests could distinguish ME/CFS from depression and somatoform disorders?
What This Study Does Not Prove
This review does not establish that ME/CFS is psychosomatic or 'all in the head'—symptom overlap with psychiatric conditions does not disprove biological mechanisms. It also does not prove the absence of neuroinflammation; rather, it notes insufficient evidence at the time of publication. This critique does not invalidate individual patient experiences or preclude future discovery of distinct biomarkers.